Ohio Man Files Actos Bladder Cancer Lawsuit
By Andrea Gressman
An Actos lawsuit has been filed after an Ohio man became another victim of damaging Actos drug side effects. The Actos lawsuit was filed against the manufacturer after the man developed bladder cancer as a result of using the Type II diabetes drug for many years. The Actos lawsuit names Takeda Pharmaceuticals America, Inc. as the defendant and was filed in the Cook County, Illinois Circuit Court on October 9, 2012 (Case No. 2011-L-010011).
Details of this New Actos Lawsuit
As described in the Actos lawsuit, the Plaintiff started taking Actos in 2002 to assist in the long-term management of his Type II diabetes. In May of 2012, he was diagnosed with bladder cancer allegedly as a direct consequence of using Actos. Since the cancer diagnosis, significant medical treatment has been required by the Actos lawsuit plaintiff to include two surgeries to remove bladder tumors. He will continue to require additional medical treatment for bladder cancer in the foreseeable future.
The History Behind Actos and the Bladder Cancer Side Effect
Actos was approved by the U.S. Food & Drug Administration (FDA) in 1999 for the treatment of Type II diabetes. One of Takeda Pharmaceuticals America Inc.’s best selling drugs, Actos, reportedly had global sales of $4.8 billion last years and comprised 27% of the company’s revenue. According to the Actos bladder cancer lawsuit, the defendants were able to meet their sales and marketing goals for the drug while concealing the information that Actos can cause bladder cancer and bladder tumors. As stated in the Actos lawsuit as evidence of this, Actos was shown to cause bladder tumors in rats over the course of a two-year animal study of the drug. Following FDA approval, two additional studies showed an increased incidence of bladder cancer in individuals who used Actos.
Also stated in the Actos lawsuit, in June 2011 the FDA issued a Drug Safety Communication warning to users that extended use of Actos increased the side effect risk of bladder cancer. This warning was the result of receipt of interim results of a 10-year study that found that people using Actos for one year saw an increased risk of bladder cancer by 40%.
The Actos lawsuit goes on to further state that Takeda recalled Actos in France after sales of the drug were suspended by French regulators as a result of its correlation to bladder cancer. At that time, Takeda failed to and reportedly refused to issue a recall of Actos in the United States.
If you or someone you love has been diagnosed with Actos bladder cancer or bladder tumors as a side effect from taking Actos, there is help for your situation. Visit the Actos Bladder Cancer Class Action Lawsuit Investigation page to learn about how to file an Actos lawsuit today. Provide your basic information and then an Actos lawsuit attorney will gladly contact you. Through a free consultation they can learn more about your situation and help you file an Actos lawsuit.
Updated October 23rd, 2012
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement
